Harrow (HROW) Change in Intangibles (2023)

Harrow (HROW) posted quarterly Change in Intangibles of $9000.0 for Q4 2023, up 100.05% quarter-over-quarter from -$19.6 million in Q3 2023.

Harrow (HROW) Change in Intangibles (2023) Analysis & Trends

Harrow's Change in Intangibles history runs 1 years deep, the most recent figure standing at $9000.0 for Q4 2023.

In Q4 2023, Change in Intangibles changed N/A year-over-year to $9000.0; the TTM figure through Dec 2023 stood at -$151.1 million (changed N/A YoY), while the FY2025 annual figure was -$215000.0, up 99.42% from the prior year.
Change in Intangibles for Q4 2023 stood at $9000.0, up from -$19.6 million in the prior quarter.
The five-year high for Change in Intangibles was $9000.0 in Q4 2023, with the low at -$130.5 million in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Intangibles (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-	-
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn	-
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	-310.09 Mn
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn	-
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn	-
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	-
10	Harrow	1.53 Bn	1.45 Bn	50.36 Mn	-

Download Data